Skip to product information

CIZUMAB 400MG INJ

Vendor: CIZUMAB
Availability: In stock
Product type: Oncology
Composition: BEVACIZUMAB
Strength: 400MG
Dosage Form: Injection

Prescription Required

Sale price  ₹ 9,200.00 Regular price  MRP: ₹ 52,800.00 83% OFF
Inclusive of all taxes.
CIZUMAB 400MG INJ
Regular price ₹ 9,200.00
Regular price ₹ 52,800.00 Sale price ₹ 9,200.00 (-83%)
Strength: 400MG
Dosage Form: Injection
CIZUMAB 400MG INJ
CIZUMAB 400MG INJ
Sale price  ₹ 9,200.00 Regular price  MRP: ₹ 52,800.00 83% OFF

Introduction

Cizumab 400mg Injection contains bevacizumab, a monoclonal antibody that inhibits vascular endothelial growth factor (VEGF), reducing tumour blood vessel formation and slowing cancer growth.

Uses

Cizumab 400mg Injection is used in combination with chemotherapy for the treatment of various cancers.

  • Colorectal cancer.
  • Lung cancer.
  • Ovarian cancer.
  • Cervical cancer.
  • Kidney cancer.
  • Glioblastoma.

Storage

  • Store refrigerated at 2°C–8°C.
  • Do not freeze or shake.
  • Protect from light until administration.

Safety Information

  • Monitor blood pressure, kidney function and urine protein regularly.
  • Inform your doctor about recent surgery, bleeding disorders or heart disease before treatment.

Possible Side Effects

Possible side effects may include:

  • High blood pressure
  • Proteinuria
  • Bleeding
  • Delayed wound healing
  • Fatigue
  • Diarrhoea
  • Blood clots
  • Infusion reactions

About RareMeds

We, at RareMeds, make a diligent attempt to deliver accurate, expert-drafted and thoroughly reviewed medicine-related information to our consumers. However, it should, by no means, be considered a substitute for a prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact, we detest any form of self-medication without expert advice.

The sole purpose of the information on our portal is to educate our consumers, which helps improve communication between a doctor and a patient. The information is by no means complete in its entirety and should not be used to diagnose or treat any medical condition.

No amount of information can replace the experience and expertise of a doctor; therefore, his/her advice always holds priority and should be followed appropriately.

Disclaimer

Cizumab is a prescription biological anticancer medicine.

It should only be administered under the supervision of a qualified oncologist.

Related Products